Anti-tumor Drugs
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
35
NCT05653869
A Study of APS03118 in Advanced Solid Tumors Harboring RET Mutations or Fusions
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 6, 2023
Completion: Apr 30, 2025
Loading map...